1. Introduction {#s0005}
===============

Metal-on-metal (MoM) hip replacements are associated with elevated failure rates due to the development of adverse reactions to metal debris (ARMD) which include osteolysis, soft tissue necrosis, pain, and benign but inflammatory pseudotumours [@bib1], [@bib2]. Tissues surrounding failed MoM joints are infiltrated by immune cells including mononuclear phagocytes [@bib3], lymphocytes [@bib4] and neutrophils [@bib3]. Once inside tissues these cells can carry out their effector functions that lead to an inflammatory response but the mechanisms by which they are recruited are currently unclear.

Cobalt ions released during wear of MoM implants activate human Toll-like receptor 4 (TLR4) [@bib5], [@bib6], [@bib7], [@bib8], an innate immune receptor expressed on the surface of numerous cell types, including macrophages, dendritic cells and endothelial cells. TLR4 is also activated by lipopolysaccharide (LPS) to protect against Gram negative bacterial infection and resulting sepsis. The recent discovery of cobalt as a TLR4 agonist has led to several studies highlighting the subsequent cellular events, specifically the release of pro-inflammatory cytokines and chemokines including interleukin-6 (IL-6), interleukin-8 (IL-8) [@bib9], chemokine (C-X-C motif) ligand 10 (CXCL10) [@bib9] and chemokine (C-C motif) ligand 2 (CCL2) [@bib10].

Chemokines are small (10--12 kDa) secreted molecules that co-ordinate the immune response. *In vivo* they form a chemokine gradient to guide target cells towards the site of inflammation, and exert their effects through G protein-coupled receptors on these cells [@bib11]. Each chemokine produces a different response within its target cell; for example IL-8 is chemotactic for neutrophils [@bib12], while CCL2 acts on monocytes to direct them to the site of inflammation [@bib13].

The individual effect of most chemokines is well-described. However the immunological outcome is dependent on the overall chemokine profile produced in response to a pathogen and the chemotactic effect of cobalt is currently unknown.

This study set out to determine the effect of cobalt ions on the migration of immune cells and the role of TLR4 in any observed responses to establish whether cobalt may contribute to the inflammatory infiltrate surrounding failed MoM hip replacements.

2. Materials and methods {#s0010}
========================

2.1. Cell culture {#s0015}
-----------------

MonoMac 6 cells are a human cell line derived from acute monocytic leukaemia. They are known to be LPS-responsive through their expression of TLR4 [@bib14]. Cells were cultured in RPMI-1640 medium (Sigma Aldrich, Gillingham, UK) supplemented with 10% FBS, 50 U/ml penicillin, 50 μg/ml streptomycin and 2 mM [L]{.smallcaps}-glutamine (all Sigma Aldrich).

2.2. Metal ion stimulation {#s0020}
--------------------------

Cobalt chloride hexahydrate (CoCl~2~) (Sigma Aldrich) was diluted in complete cell culture media prior to cell stimulation. MonoMac 6 cells were treated with 0.75 mM CoCl~2~, a clinically-relevant concentration optimised in a previous study [@bib9]. 100 ng/ml TLR4-specific LPS (from *E.coli* serotype J5, Alexis Biochemicals, San Diego, USA) as a positive control for 24 h after which supernatant (termed \'conditioned media\') was collected.

2.3. TLR4 antagonist {#s0025}
--------------------

CLI-095 (Invivogen, Toulouse, France) is a small molecule antagonist that binds to the intracellular domain of TLR4 to prevent recruitment of adaptor proteins and subsequent downstream signalling. MonoMac 6 cells were pre-treated with 1 μg/ml CLI-095 for 6 h prior to stimulation with 0.75 mM CoCl~2~ or 100 ng/ml LPS. **Enzyme-linked immunosorbent assay (ELISA)**.

Cytokine secretion was quantified by enzyme-linked immunosorbent assay (ELISA). An IL-6 ELISA kit (Peprotech, London, UK) was used according to the manufacturer's protocol with the same minor modification as described previously for an IL-8 ELISA [@bib9]. CCL20 was quantified using a DuoSet ELISA kit (R&D Systems, Abingdon, UK) according to the manufacturer's protocol.

2.4. Monocyte and neutrophil isolation {#s0030}
--------------------------------------

Monocytes and neutrophils were isolated from whole blood of healthy volunteers. Monocytes were isolated using Lympholyte (Cedarlane, Burlington, USA) according to the manufacturer\'s protocol and neutrophils were isolated by dextran sedimentation (Dextran T500, Pharmacosmos, Holbaek, Denmark) and centrifugation on Percoll (GE Healthcare, Buckinghamshire, UK) density gradients as previously described [@bib15].

2.5. Transwell migration assay {#s0035}
------------------------------

Following isolation cells were resuspended in RPMI-1640 medium (Sigma Aldrich) supplemented with 10% FBS and 2 mM [L]{.smallcaps}-glutamine. Conditioned media from MonoMac 6 cells was added to the lower chamber of a 24-well companion plate (BD Falcon, New Jersey, USA). LPS conditioned media was used as a positive control and complete RPMI-1640 media provided a negative control. Three technical replicates were included for each condition. A Falcon cell culture insert with 3 µm pores (VWR Systems, Pennsylvania, USA) was placed in each well. 500,000 monocytes or neutrophils were added to the upper chamber of each filter and incubated at 37 °C for 2 h to allow for chemotaxis. Migrated monocytes and neutrophils pass through the pores in the cell culture insert and adhere to the underside of the filter.

Filters were fixed in methanol before staining migrated cells with haematoxylin. Following fixation, filters were air-dried for 3 h, excised, and mounted using DPX mountant (Sigma Aldrich). Five different visual fields were selected per filter and attached cells were counted at ×40 magnification.

2.6. Statistical analysis {#s0040}
-------------------------

Data was analysed using GraphPad Prism 6 software (GraphPad, California, USA). A Student's *t* test was used for statistical analysis unless otherwise stated, with p\<0.05 considered significant. All error bars show the standard error of the mean (SEM).

3. Results {#s0045}
==========

We have previously described TLR4-dependent IL-8 and CXCL10 secretion by cobalt-stimulated MonoMac 6 cells [@bib9], as well as increased *CCL20* and *IL1A* expression [@bib16]. For the present study we have further investigated the effects of cobalt-mediated TLR4 activation on cytokine secretion by studying CCL20 and IL-6. MonoMac 6 cells were pre-treated with 1 μg/ml CLI-095 for 6 h prior to 24 h stimulation with 0.75 mM CoCl~2~ or 100 ng/ml TLR4-specific LPS as a positive control. In response to CoCl~2~ there was a significant increase in CCL20 secretion to approximately 300 pg/ml (*P*\<0.001) ([Fig. 1](#f0005){ref-type="fig"}A). Pre-treatment with the TLR4 antagonist decreased CoCl~2~-mediated CCL20 release to \<10 pg/ml (*P*\<0.001). This was comparable to the CCL20 response to LPS, which was also significantly increased by the ligand and inhibited by CLI-095 (both *P*\<0.001) ([Fig. 1](#f0005){ref-type="fig"}A). LPS increased IL-6 secretion by MonoMac 6 cells to approximately 2000 pg/ml (*P*\<0.001), and this was significantly inhibited by CLI-095 (*P*\<0.001) ([Fig. 1](#f0005){ref-type="fig"}B). In response to CoCl~2~ stimulation there was also a significant upregulation in IL-6 release but only to 350 pg/ml (*P*=0.045) ([Fig. 1](#f0005){ref-type="fig"}B). Although CLI-095 reduced CoCl~2~-mediated IL-6 release to approximately 50 pg/ml, this did not reach statistical significance (*P*=0.080) ([Fig. 1](#f0005){ref-type="fig"}B). However from the data obtained it is clear that cobalt ions can increase secretion of pro-inflammatory cytokines and chemokines through activation of TLR4.Fig. 1Effect of cobalt-mediated TLR4 activation on CCL20 and IL-6 secretion. MonoMac 6 cells were pre-treated with 1 μg/ml CLI-095 for 6 h prior to 24 h stimulation with 0.75 mM CoCl~2~ or 100 ng/ml LPS. A. CCL20 and B. IL-6 secretion was assessed by ELISA. Data is representative of three independent experiments and statistical significance was calculated by one-way ANOVA with Tukey\'s test for multiple comparisons comparing al samples to each other.Fig. 1

The effect of cobalt ions on monocyte and neutrophil chemotaxis was investigated due to the presence of these innate immune cells around failed MoM implants, increased chemokine secretion in response to cobalt, and the role of TLR4 in innate immunity [@bib9], [@bib10], [@bib17]. The TLR4 antagonist CLI-095 has previously been shown to inhibit cobalt-induced chemokine secretion by MonoMac 6 cells [@bib9] and was used to investigate the role of TLR4 in cobalt-mediated monocyte and neutrophil chemotaxis.

MonoMac 6 cells were left untreated or pre-treated with 1 μg/ml CLI-095 for 6 h, followed by 24 h treatment with 100 ng/ml LPS or 0.75 mM CoCl~2~. A transwell migration assay was then conducted using the conditioned media. Monocyte chemotaxis was significantly upregulated in response to CoCl~2~ conditioned media compared to the untreated control (*P*\<0.001) ([Fig. 2](#f0010){ref-type="fig"}A and B). This increase was significantly inhibited by pre-treatment of MonoMac 6 cells with CLI-095 (*P*\<0.001). Monocyte migration was also increased in response to conditioned media from TLR4-specific LPS and the effect was also abrogated by CLI-095 (*P*\<0.001) demonstrating that CLI-095 specifically inhibits the TLR4 signalling pathway. Untreated conditioned media did not affect monocyte chemotaxis and there was no difference with the addition of CLI-095 (*P*=0.78). This shows that CLI-095 alone does not affect chemokine secretion, nor does it cause monocyte chemotaxis down a concentration gradient.Fig. 2Effect of cobalt ions on monocyte chemotaxis. A. Filters stained with haematoxylin showing migrated monocytes at ×40 magnification. B. Migrated monocytes were counted at ×40 magnification. There was a significant increase in monocyte migration in response to 0.75 mM CoCl~2~ and 100 ng/ml LPS (24 h treatment) conditioned media compared to untreated controls. 1 µg/ml CLI-095 abrogated the CoCl~2~-induced effect (*P*\<0.001). The effect of LPS was also inhibited demonstrating that the antagonist is specific for TLR4. CLI-095 had no effect on migration in untreated controls (*P*=0.78). Data is representative of three independent experiments each using a different monocyte donor. \*\*\*=*P*\<0.001, Student\'s *t*-test.Fig. 2

Neutrophil chemotaxis was also investigated and similar effects were observed to those in monocytes ([Fig. 3](#f0015){ref-type="fig"}A and B). Cobalt conditioned media induced neutrophil chemotaxis (*P*\<0.001) and was significantly decreased in the presence of the TLR4 inhibitor (*P*\<0.001), as was LPS-stimulated migration as a positive control (*P*\<0.001). The untreated controls with and without CLI-095 had no effect on neutrophil migration and were not significantly different from each other (*P*=0.61).Fig. 3Effect of cobalt ions on neutrophil chemotaxis. A. Filters stained with haematoxylin showing migrated neutrophils at ×40 magnification. B. Migrated neutrophils were counted at ×40 magnification. Neutrophil migration was significantly increased in response to 0.75 mM CoCl~2~ and 100 ng/ml LPS (24 h) conditioned media from MonoMac 6 cells compared to untreated controls. 1 µg/ml CLI-095 significantly abrogated the observed CoCl~2~-mediated chemotaxis (*P*\<0.001). LPS-induced neutrophil chemotaxis was also inhibited by CLI-095 (*P*\<0.001). Data is representative of three independent experiments each using a different neutrophil donor. \*\*\*=*P*\<0.001, Student\'s *t*-test.Fig. 3

4. Discussion {#s0050}
=============

This study set out to determine the chemotactic properties of cells stimulated with cobalt ions and the role of TLR4 in these responses. We have clearly shown that cobalt-mediated activation of TLR4 increases the release of inflammatory cytokines, specifically CCL20 and IL-6. This supports out previous work showing similar effects on release of IL-8 and CXCL10 [@bib9]. Furthermore, we have demonstrated that conditioned media from cobalt-stimulated MonoMac 6 cells causes increased chemotaxis of primary monocytes and neutrophils. The observed monocyte and neutrophil chemotaxis can be attributed to TLR4 as the small molecule TLR4 antagonist CLI-095 abrogated the response. This demonstrates that chemokines capable of attracting innate immune cells are secreted via direct cobalt activation of the TLR4 signalling pathway.

Given the increased chemokine secretion observed in response to cobalt in previous studies it could be assumed that any conditioned media from cobalt-stimulated cells would be chemotactic. However it is important to note that many cytokines and chemokines, such as IL-10, can dampen an inflammatory response in order to modulate immunity and prevent systemic shock [@bib18], [@bib19]. Furthermore, while research has shown that cobalt induces certain individual pro-inflammatory factors including IL-8 [@bib9] and CCL2 [@bib10], it is the cumulative effect of chemokines that ultimately influences migration. Before the current study it was not fully understood whether cobalt ions would cause a chemotactic response or induce a chemokine profile that skewed the response against migration. Data presented here shows clearly that the overall cobalt-induced chemokine profile in monocytes is pro-migratory for both primary monocytes and neutrophils.

Based on our understanding of the effects of factors such as IL-8 and CCL2 on neutrophil and monocyte migration respectively, coupled with their known secretion in response to TLR4 activation by cobalt [@bib9], [@bib20], it can be surmised that they are at least in part responsible for the observed chemotaxis. Future work will involve neutralising different chemokines and their receptors to further investigate their individual role in the chemotaxis response to cobalt ions. Work will also be undertaken to determine whether or not the migration of monocytes and neutrophils affects subsequent recruitment of adaptive immune cells such as lymphocytes, which are also known to be present around failed MoM hip replacements [@bib4], [@bib21].

In conclusion, this study demonstrates the role of TLR4 in cobalt-mediated inflammatory cytokine secretion and innate immune cell chemotaxis, and highlights TLR4 as a potential therapeutic target in preventing inflammatory cell infiltration of MoM peri-implant tissues.
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